サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1373874

非経口栄養剤の世界市場 - 市場規模、シェア、成長分析：消費者別、エンドユーザー別 - 業界予測（2023年～2030年）

Global Parenteral Nutrition Market Size, Share, Growth Analysis, By Consumer(Children and Newborns, and Adults), By End user(Clinics, Hospitals) - Industry Forecast 2023-2030
出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
非経口栄養剤の世界市場 - 市場規模、シェア、成長分析：消費者別、エンドユーザー別 - 業界予測（2023年～2030年）
出版日: 2023年10月13日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の非経口栄養剤の市場規模は2021年に63億3,000万米ドル、2022年に67億1,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に6.0%のCAGRで拡大し、2030年には107億米ドルに成長する見通しです。

世界の非経口栄養剤市場は過去数年間で大きな成長を遂げており、今後も拡大が続くと予想されています。世界の非経口栄養剤市場の成長を促進する主な要因の1つは、慢性疾患と消化器疾患の有病率の増加です。がん、クローン病、短腸症候群などの疾患では、十分な栄養を確保し患者の回復をサポートするために非経口栄養剤の使用が必要となります。さらに、栄養不良や関連合併症を起こしやすい高齢者人口が増加していることも、市場の成長に寄与しています。市場拡大を促進するもう1つの要因は、非経口栄養製剤と技術の進歩です。メーカー各社は、患者の転帰を改善し、合併症を軽減し、投与の容易性を高める革新的な製品の開発に注力しています。例えば、栄養素の組み合わせをカスタマイズできるマルチチャンバーバッグの導入は、非経口栄養溶液の調製プロセスを簡素化し、医療従事者と患者の双方にメリットをもたらしています。しかし、世界の非経口栄養市場はいくつかの課題にも直面しています。重大な障害のひとつは、長期の非経口栄養療法に伴う感染症や合併症のリスクです。カテーテル関連の血流感染や代謝合併症は患者に大きなリスクをもたらすため、厳格な感染管理対策と慎重なモニタリングが必要となります。さらに、非経口栄養液や関連機器のコストが高いため、特にヘルスケア予算が限られている新興国市場では、市場の成長が制限される可能性があります。

革新的な製剤、改良された栄養素の組み合わせ、および高度な送達システムの開発により、非経口栄養療法の安全性と有効性が向上しています。これらの進歩により、非経口栄養投与は医療提供者にとってより便利なものとなり、患者にとってはより忍容性の高いものとなっています。

全般的な健康および疾患管理における栄養の重要性に対する認識が高まっています。患者の転帰における栄養の役割に対するこのような理解の高まりは、包括的なヘルスケアの一環としての非経口栄養療法に対する需要の高まりにつながっています。

地域によって非経口栄養療法に関する規制が異なり、ガイドラインも標準化されていないため、メーカーやヘルスケアプロバイダーにとって課題となっています。非経口栄養の安全かつ効果的な投与を確保するためには、規制の枠組みの調和とエビデンスに基づくガイドラインの策定が不可欠です。

非経口栄養への長期依存は、肝機能障害、水分不均衡、電解質異常などの合併症を呈することがあります。非経口栄養の最適な使用を確保し、患者へのリスクを最小限に抑えるためには、こうした制限や合併症を注意深く管理する必要があります。

当レポートは、世界の非経口栄養剤市場について調査し、市場の概要とともに、消費者別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

親市場分析

市場規模

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要な市場の洞察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 動向分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品分析
  • マクロ経済指標
  • トップ投資分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制状況
  • ポーター分析

世界の非経口栄養剤市場、消費者別

  • 市場概要
  • 小児、新生児
  • 成人

世界の非経口栄養剤市場、エンドユーザー別

  • 市場概要
  • クリニック
  • 病院
  • その他

世界の非経口栄養剤市場、地域別

  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

競合情勢

  • 主要企業プロファイル
    • Fresenius Kabi
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Grifols SA
    • Otsuka Pharmaceutical Co., Ltd.
    • Pfizer Inc.
    • Aculife Healthcare Pvt. Ltd.
    • Vifor Pharma
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • ALLERGAN
    • Claris Lifesciences Limited
    • Actavis plc
    • ABBOTT
    • AstraZeneca
    • Medtronic
    • Beximco Pharmaceuticals Ltd.
    • Sichuan Luye Pharmaceutical Co., Ltd.
    • ICU Medical, Inc.
    • JW Pharmaceutical Corporation
    • Hospira, Inc.
目次
Product Code: SQMIG35C2016

Global Parenteral Nutrition Market size was valued at USD 6.33 Billion in 2021 and is poised to grow from USD 6.71 Billion in 2022 to USD 10.7 Billion by 2030, at a CAGR of 6.0% during the forecast period (2023-2030).

The global parenteral nutrition market has experienced significant growth over the past years and is expected to continue expanding in the coming years. One of the key drivers fueling the growth of the global parenteral nutrition market is the increasing prevalence of chronic diseases and gastrointestinal disorders. Conditions such as cancer, Crohn's disease, and short bowel syndrome necessitate the use of parenteral nutrition to ensure adequate nutrition and support patient recovery. Moreover, the rising geriatric population, who are more prone to malnutrition and related complications, has contributed to the market growth. Another factor driving market expansion is the advancements in parenteral nutrition formulations and technologies. Manufacturers are focusing on developing innovative products that improve patient outcomes, reduce complications, and enhance the ease of administration. For instance, the introduction of multi-chamber bags that allow for customized nutrient combinations has simplified the process of preparing parenteral nutrition solutions, benefiting both healthcare professionals and patients. However, the global parenteral nutrition market also faces several challenges. One of the significant hurdles is the risk of infections and complications associated with long-term parenteral nutrition therapy. Catheter-related bloodstream infections and metabolic complications pose substantial risks to patients, requiring stringent infection control measures and careful monitoring. Furthermore, the high cost of parenteral nutrition solutions and associated equipment can limit market growth, especially in developing regions with limited healthcare budgets.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Parenteral Nutrition Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Nutrition Market Segmental Analysis

The global parenteral nutrition market is segmented on the basis of consumer, end user, and region. By consumer, the market is segmented into Children and Newborns, and Adults. By end user, the market is segmented into Clinics, Hospitals, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Parenteral Nutrition Market Dynamics

Drivers of the Global Parenteral Nutrition Market

Technological Advancements in Parenteral Nutrition Products

The development of innovative formulations, improved nutrient combinations, and advanced delivery systems has enhanced the safety and efficacy of parenteral nutrition therapy. These advancements have made parenteral nutrition administration more convenient for healthcare providers and more tolerable for patients.

Increasing Awareness about Clinical Nutrition

There is a growing awareness of the importance of nutrition in overall health and disease management. This increased understanding of the role of nutrition in patient outcomes has led to a higher demand for parenteral nutrition therapy as a part of comprehensive healthcare.

Restraints in the Global Parenteral Nutrition Market

Regulatory Constraints and Lack of Standardization

Variations in regulations and lack of standardized guidelines for parenteral nutrition therapy across different regions pose challenges for manufacturers and healthcare providers. Harmonization of regulatory frameworks and the development of evidence-based guidelines are essential for ensuring safe and effective administration of parenteral nutrition.

Potential Complications and Limitations of Long-term Use

Prolonged dependence on parenteral nutrition may present complications such as liver dysfunction, fluid imbalances, and electrolyte abnormalities. These limitations and complications need to be carefully managed to ensure the optimal use of parenteral nutrition and minimize risks to patients.

Market Trends of Global Parenteral Nutrition Key

Integration of Digital Health Technologies: Digital health technologies, such as mobile applications, connected devices, and telehealth solutions, are being integrated into parenteral nutrition therapy. These technologies enable remote monitoring, real-time data collection, and improved communication between patients, caregivers, and healthcare providers, leading to better patient management and enhanced treatment outcomes.

Focus on Quality Control and Product Safety: With the increasing importance of patient safety, there is a growing focus on quality control and product safety in the manufacturing and administration of parenteral nutrition solutions. Companies are implementing stringent quality assurance processes, adhering to regulatory guidelines, and investing in technologies to ensure the safety and efficacy of their products.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Parenteral Nutrition Market by Consumer
    • Market Overview
    • Children and Newborns
    • and Adults
  • Global Parenteral Nutrition Market by End user
    • Market Overview
    • Clinics
    • Hospitals
    • and Others
  • Global Parenteral Nutrition Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Fresenius Kabi (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Grifols SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Aculife Healthcare Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vifor Pharma (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sichuan Kelun Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ALLERGAN (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Claris Lifesciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Actavis plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ABBOTT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Beximco Pharmaceuticals Ltd. (Bangladesh)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sichuan Luye Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ICU Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • JW Pharmaceutical Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Hospira, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments